News 11 Oct. 2023
Curtis Team Instrumental in Shareholder Approval of a New Multilateral Treaty to Transform Pan-African Housing Finance Institution Shelter Afrique into a Development Bank
more
Event 23 Aug. 2023
Partner Borzu Sabahi Speaks at the 52nd IDRI Professional Accreditation & Membership Programme
Event 18 Aug. 2023
Partner Borzu Sabahi Speaks at FDI Moot Shenzhen
News 25 Jul. 2023
Partner Eric Gilioli Ranked in Top 10 Influential Energy & Natural Resources Lawyers in Kazakhstan in Business Today
Article 22 Aug. 2023
Fuad Zarbiyev Publishes Article in Journal of International Economic Law
Client Alert 14 Aug. 2023
The EU’s Market in Crypto Assets (MiCA) Regulation: The Highlights
Event 22 Aug. 2023
Partner Dr. Claudia Frutos-Peterson to Speak at Arbitration and ADR Commission of the ICC Mexico
Event 11 Jul. 2023
Partner Elisa Botero Speaks on the Role of the ICC in Investment Disputes
News 15 Aug. 2023
Legal Reader Publishes Article on Dr. Majed Alotaibi’s Arrival as Senior Counsel in Curtis’ Riyadh Office
News 31 Jul. 2023
Curtis Welcomes Senior Saudi Advisor, Dr. Majed Alotaibi, to its Riyadh Office
News 24 Aug. 2023
Curtis Attorneys Quoted in CoinDesk on FTX Founder Sam Bankman-Fried’s Strategy Ahead of His Criminal Trial
News 06 Mar. 2023
Russia Sanctions at the First Anniversary: An Overview of Current Sanctions in the US, UK, and EU and How Global Companies Can Navigate Evolving and Conflicting Sanctions Regimes
Client Alert 30 Aug. 2022
The EU Adopts the “Maintenance and Alignment” Sanctions Package
Client Alert 24 Jun. 2021
Update on Virtual Notarization (Executive Order 202.7) During the COVID-19 (Coronavirus) Pandemic (Updated: June 24, 2021) — U.S. Insight
Update on Virtual Witnessing (New York Executive Order 202.14) During The COVID-19 (Coronavirus) Pandemic (Updated: June 24, 2021) — U.S. Insight
Publications February 2009
The UK Financial Services Authority (FSA) recently adopted the Short Selling (No. 5) Instrument 2009 (the Short Selling Instrument), which ends the ban on short selling in UK financial sector companies, and extends the disclosure requirements for significant short positions held in such companies until 30 June 2009. The Short Selling Instrument came into force on 16 January 2009. The FSA considers non-compliance with the Short Selling Instrument provisions to amount to market abuse under the Financial Services and Markets Act 2000, and as such non-compliance may result in the same consequences as any other breach of the market abuse regime, including a fine or a public censure. The list of companies whose securities are affected is available at: http://www.fsa.gov.uk/pubs/other/Shortselling_list.pdf
Amended Disclosure RequirementsSince 18 September 2008, the FSA has required the daily disclosure of investors' net short position of 0.25% or more of the issued share capital of a UK company held at market close on the previous working day (the Disclosure Obligation).
The Short Selling Instrument amends the Disclosure Obligation so that once made, further disclosures are only required on a short position changing, reaching, exceeding or falling below disclosure bands placed every 0.1% above the 0.25% threshold, i.e., at 0.35%, 0.45%, etc. In addition, a final disclosure is required when a position decreases below 0.25%. The holder of such position is required to disclose it to the market via a Regulatory Information Service (RIS) announcement by 3:30 p.m. on the business day following the day the Disclosure Obligation arises.
Exceptions
Market-makers continue to be exempt from the Disclosure Obligation. For the purposes of the Short Selling Instrument, the FSA considers as market-makers entities that, as part of their business, ordinarily deal as principals in equities, options or derivatives, whether OTC or exchange-traded, to fulfill orders received from clients, to respond to a client's request to trade or to hedge positions arising out of those dealings, and/or in a way that ordinarily has the effect of providing liquidity on a regular basis to the market on both bid and offer sides of the market in comparable size. Trading in circumstances other than genuinely for the provision of liquidity is not exempt.
Carl A. Ruggiero
Partner
We use cookies on our website to enhance your browsing experience, match your interests and assess our website performance. We do not share information with any third-party for marketing purposes. Please view our privacy policy to learn more about the use of cookies on our website. By continuing to browse our website, you consent to our use of cookies.